230 related articles for article (PubMed ID: 32190695)
21. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
22. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
[TBL] [Abstract][Full Text] [Related]
23. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
24. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
Wang J; Zhou C; Zhang Q; Liu Z
Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
[TBL] [Abstract][Full Text] [Related]
25. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
[TBL] [Abstract][Full Text] [Related]
26. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
Hasegawa S; Inagi R
Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
[TBL] [Abstract][Full Text] [Related]
27. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
[TBL] [Abstract][Full Text] [Related]
28. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
29. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
Tavares G; Venturini G; Padilha K; Zatz R; Pereira AC; Thadhani RI; Rhee EP; Titan SMO
Metabolomics; 2018 Feb; 14(4):39. PubMed ID: 30830377
[TBL] [Abstract][Full Text] [Related]
30. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
31. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
33. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
[TBL] [Abstract][Full Text] [Related]
34. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
Zhang H; Hu W; Zhang G
Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with the development of diabetic kidney disease in Sudanese patients with type 2 diabetes mellitus: A case-control study.
Shigidi MM; Karrar WN
Diabetes Metab Syndr; 2021; 15(6):102320. PubMed ID: 34700293
[TBL] [Abstract][Full Text] [Related]
36. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review.
Das S; Devi Rajeswari V; Venkatraman G; Elumalai R; Dhanasekaran S; Ramanathan G
Transl Res; 2024 Mar; 265():71-87. PubMed ID: 37952771
[TBL] [Abstract][Full Text] [Related]
37. Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease.
Drexler Y; Fornoni A
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37843281
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
[TBL] [Abstract][Full Text] [Related]
39. REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease.
Wang X; Wu H; Yang G; Xiang J; Xiong L; Zhao L; Liao T; Zhao X; Kang L; Yang S; Liang Z
Front Endocrinol (Lausanne); 2022; 13():935796. PubMed ID: 35937821
[TBL] [Abstract][Full Text] [Related]
40. Serum haptoglobin levels are associated with renal function decline in type 2 diabetes mellitus patients in a Chinese Han population.
Huang Y; Huang Y; Zhang R; Jin L; Zhang H; Hu C
Diabetes Res Clin Pract; 2019 Oct; 156():107865. PubMed ID: 31545979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
